This page, Massachusetts COVID-19 Vaccine Program (MCVP) Overview, is part of
This page, Massachusetts COVID-19 Vaccine Program (MCVP) Overview, is offered by

Massachusetts COVID-19 Vaccine Program (MCVP) Overview

The Massachusetts Department of Public Health (DPH) Immunization Division is working with the Centers for Disease Control (CDC) to distribute the COVID-19 vaccine.

The information on this page will assist you in your vaccination efforts throughout the pandemic. Below are updates and resources for the Massachusetts COVID-19 Vaccine Program (MCVP).

Table of Contents

Who can administer the COVID-19 vaccine?

This COVID-19 Vaccinators chart (updated March 30, 2021) lists the different groups of individuals who can possess and administer COVID-19 vaccines.

Eligibility to receive COVID-19 vaccine supply

All providers participating in the Massachusetts COVID-19 Vaccine Program (MCVP) are required to sign an MCVP Agreement to receive delivery of any COVID-19 vaccine.

  • Providers must be registered with the Massachusetts Immunization Information System (MIIS), in order to submit immunization administration data.
  • Providers registered with the MIIS all received the MCVP Agreement. New sites that register with the MIIS will receive the Agreement automatically. If you have not received the Agreement, contact the DPH Vaccine Unit at DPH-Vaccine-Management@massmail.state.ma.us. The MCVP Agreement must be completed in order to receive vaccine.
  • Providers must complete the onboarding process with the MIIS User Support Team to ensure that immunization data are being sent to the MIIS registry.

Additional resources:

Storage, handling, administration and safety

COVID-19 Vaccine Storage, Handling, Administration and Safety Training

The MDPH Immunization Division is pleased to present a free accredited COVID-19 Vaccine training. MDPH strongly encourages the primary and back-up vaccine coordinators at each site and providers administering COVID-19 vaccine to complete the trainings in vaccine storage, handling, administration and safety found at the link below. Information in this training is based on information currently available at the time of the recordings and modules will be updated as necessary. A certificate of completion will be awarded immediately upon successful completion of all training modules and passing the proficiency quiz. Continuing education credits can be earned for completing all modules.

This training is divided into modules so the learner can complete each module when they have time and do not have to complete the entire training all at one time.  Another benefit of this online training is that the learner can go back into the training site and re-review the content as often as they choose even after completion of the training. 

MDPH COVID-19 Vaccine Training – Storage, Handling, Administration and Safety

Routine vaccination during COVID

Routine vaccination is essential to protecting our communities against vaccine preventable diseases. CDC and DPH recommend that routine vaccinations are maintained throughout the COVID-19 pandemic. CDC recommends that provider offices identify children due for vaccination and schedule appointments starting with newborns and children up to 24 months, young children, and adolescents. For more information on immunization services during the COVID-19 Pandemic visit www.cdc.gov/vaccines/pandemic-guidance

FDA Emergency Use Authorization (EUA)

Johnson & Johnson/Janssen COVID-19 Vaccine

Pfizer-BioNTech COVID-19 Vaccine

Moderna COVID-19 Vaccine

Materials to Support Moderna EUA Changes – April 2021

With the FDA’s EUA revisions announced April 1, the Moderna vaccine will be available in two different vials by early May: the current Maximum 11 dose vial and a new Maximum 15 dose vial. CDC resources:

Feedback